Financial Statements Directors’ Report for the year ended 31 December 2024 DIRECTORS’ INTERESTS (continued) Number of ordinary shares of TL2.00 each At 1 January 2024 Options exercised Bought Sold At 31 December 2024 Interests in a subsidiary International Hospital Istanbul A.S. Mehmet Ali Aydinlar − Direct 1 – – – 1 − Deemed 1 – – – 1 Except as disclosed above, none of the other Directors holding office as at 31 December 2024 had any interest in the ordinary shares and options over ordinary shares of the Company and of its related corporations during the financial year. DIRECTORS’ BENEFITS Since the end of the previous financial year, no Director of the Company has received nor become entitled to receive any benefit (other than as disclosed in the financial statements) by reason of a contract made by the Company or a related corporation with the Director or with a firm of which the Director is a member, or with a company in which the Director has a substantial financial interest, other than certain Directors who have substantial financial interests in companies which traded with certain companies in the Group in the ordinary course of business as disclosed in note 35 to the financial statements. There were no arrangements during and at the end of the financial year which had the object of enabling Directors of the Company to acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate. IHH Healthcare Berhad | Annual Report 2024 116
RkJQdWJsaXNoZXIy NDgzMzc=